ES2055427T3 - Agente terapeutico. - Google Patents
Agente terapeutico.Info
- Publication number
- ES2055427T3 ES2055427T3 ES90906939T ES90906939T ES2055427T3 ES 2055427 T3 ES2055427 T3 ES 2055427T3 ES 90906939 T ES90906939 T ES 90906939T ES 90906939 T ES90906939 T ES 90906939T ES 2055427 T3 ES2055427 T3 ES 2055427T3
- Authority
- ES
- Spain
- Prior art keywords
- chemiopapain
- processes
- therapeutic agent
- discs
- chemiopathine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003814 drug Substances 0.000 title 1
- 229940124597 therapeutic agent Drugs 0.000 title 1
- 238000000034 method Methods 0.000 abstract 3
- 241000124008 Mammalia Species 0.000 abstract 1
- 230000002159 abnormal effect Effects 0.000 abstract 1
- 238000004587 chromatography analysis Methods 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Steroid Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Compounds Of Unknown Constitution (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Detergent Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB898909836A GB8909836D0 (en) | 1989-04-28 | 1989-04-28 | Therapeutic agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2055427T3 true ES2055427T3 (es) | 1994-08-16 |
Family
ID=10655944
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES90906939T Expired - Lifetime ES2055427T3 (es) | 1989-04-28 | 1990-04-27 | Agente terapeutico. |
Country Status (34)
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8909836D0 (en) * | 1989-04-28 | 1989-06-14 | Boots Co Plc | Therapeutic agent |
| JPH06506921A (ja) * | 1991-02-22 | 1994-08-04 | ザ・デュポン・メルク・ファーマシュウティカル・カンパニー | 置換α−アミノアルデヒドおよび誘導体 |
| CA2061861A1 (en) * | 1991-03-04 | 1992-09-05 | Jonathan Duvick | Plant polypeptides with inhibitory activity towards pathogenic microorganisms |
| CN1060519C (zh) * | 1991-05-09 | 2001-01-10 | 广西亚热带作物研究所 | 桄榔植物蛋白酶的提取方法 |
| AU668110B2 (en) * | 1991-10-14 | 1996-04-26 | Cash Engineering Research Pty Ltd | Inlet control combination for a compressor system |
| US6753006B1 (en) | 1993-02-22 | 2004-06-22 | American Bioscience, Inc. | Paclitaxel-containing formulations |
| WO1994028012A1 (en) * | 1993-05-28 | 1994-12-08 | Warner-Lambert Company | Hydroxamate inhibitors of endothelin converting enzyme |
| EP1159273A1 (en) | 1999-03-02 | 2001-12-05 | Boehringer Ingelheim Pharmaceuticals Inc. | Compounds useful as reversible inhibitors of cathepsin s |
| DK1178958T3 (da) | 1999-03-15 | 2004-06-21 | Axys Pharm Inc | N-cyanomethylamider som proteaseinhibitorer |
| US6420364B1 (en) | 1999-09-13 | 2002-07-16 | Boehringer Ingelheim Pharmaceuticals, Inc. | Compound useful as reversible inhibitors of cysteine proteases |
| US6703040B2 (en) * | 2000-01-11 | 2004-03-09 | Intralytix, Inc. | Polymer blends as biodegradable matrices for preparing biocomposites |
| SI1593391T1 (sl) | 2002-12-25 | 2013-11-29 | Komori, Hiromichi | Zdravilo za degenerativne intervertebralne diske |
| US7169405B2 (en) * | 2003-08-06 | 2007-01-30 | Warsaw Orthopedic, Inc. | Methods and devices for the treatment of intervertebral discs |
| WO2006004226A1 (en) * | 2004-07-06 | 2006-01-12 | Y S Therapeutics Co Ltd | Compositions for cancer prevention, treatment, or amelioration comprising papaya extract |
| CN1320111C (zh) * | 2004-08-09 | 2007-06-06 | 王美岭 | 一种制备木瓜凝乳酶的方法 |
| US20060241566A1 (en) * | 2005-04-11 | 2006-10-26 | Orthox, Llc | Nucleus Extraction from Spine Intervertebral Disc |
| US8642060B2 (en) * | 2006-04-24 | 2014-02-04 | Warsaw Orthopedic, Inc. | Controlled release systems and methods for osteal growth |
| US8642059B2 (en) | 2006-04-24 | 2014-02-04 | Warsaw Orthopedic, Inc. | Controlled release systems and methods for intervertebral discs |
| US7771414B2 (en) * | 2006-04-24 | 2010-08-10 | Warsaw Orthopedic, Inc. | Controlled release devices for therapeutic treatments of spinal discs |
| US7879027B2 (en) * | 2006-04-24 | 2011-02-01 | Warsaw Orthopedic, Inc. | Controlled release devices for fusion of osteal structures |
| US20070265633A1 (en) * | 2006-05-11 | 2007-11-15 | Moon Jon K | Implement and method to extract nucleus from spine intervertebral disc |
| US8257938B2 (en) * | 2009-02-27 | 2012-09-04 | Medical Diagnostic Laboratories, Llc | Hemolysin and its protein fragments in sero-detection of Anaplasma phagocytophilum |
| WO2013038936A1 (ja) * | 2011-09-13 | 2013-03-21 | タカラバイオ株式会社 | ペルオキシダーゼ反応の停止方法及び反応停止剤 |
| US9375519B2 (en) | 2012-06-25 | 2016-06-28 | Surmodics, Inc. | Bioerodable poly(etheresteramides) and medical article uses |
| CN118878631B (zh) * | 2024-06-05 | 2025-04-04 | 中国海洋大学 | 一种基于配体垂钓筛选合成牡蛎ace抑制肽的方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE270723C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | ||||
| US2313875A (en) * | 1940-12-17 | 1943-03-16 | Eugene F Jansen | Proteolytic enzyme process |
| US3320131A (en) * | 1964-10-23 | 1967-05-16 | Baxter Laboratories Inc | Method for the treatment of herniation of intervertebral discs |
| US3558433A (en) * | 1967-11-07 | 1971-01-26 | Baxter Laboratories Inc | Process for purification of chymopapain |
| YU40433B (en) * | 1975-02-20 | 1986-02-28 | Lek Tovarna Farmacevtskih | Process for obtaining pure, proteolytically active anzymes |
| DE3212846A1 (de) | 1981-04-13 | 1982-11-04 | Sintokogio, Ltd., Nagoya, Aichi | Apparat und verfahren zum herstellen eines kerns |
| US4439423A (en) * | 1981-05-13 | 1984-03-27 | Smith Laboratories, Inc. | Chymopapain and method for its use |
| US4719108A (en) * | 1981-05-13 | 1988-01-12 | Smith Laboratories, Inc. | Chymopapain composition and method for its use |
| US4374926A (en) * | 1981-05-13 | 1983-02-22 | Smith Laboratories, Inc. | Method for the production of improved chymopapain |
| EP0065395B1 (en) * | 1981-05-13 | 1988-08-24 | BOOTS-FLINT, INC. (a Delaware corp.) | Improved chymopapain and method for its production and use |
| WO1984000365A1 (en) * | 1982-07-19 | 1984-02-02 | Nat Res Dev | Synthetic peptides and their preparation |
| GB2156821A (en) * | 1984-04-03 | 1985-10-16 | Simmons James W | Process for purifying chymopapain |
| HU196624B (en) * | 1986-12-08 | 1988-12-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing chymopapain with high specific activity |
| GB8909836D0 (en) * | 1989-04-28 | 1989-06-14 | Boots Co Plc | Therapeutic agent |
-
1989
- 1989-04-28 GB GB898909836A patent/GB8909836D0/en active Pending
-
1990
- 1990-04-26 GR GR900100315A patent/GR1001011B/el unknown
- 1990-04-26 IN IN327/MAS/90A patent/IN170683B/en unknown
- 1990-04-27 DE DE69010199T patent/DE69010199T2/de not_active Expired - Fee Related
- 1990-04-27 US US07/768,325 patent/US5380656A/en not_active Expired - Fee Related
- 1990-04-27 IL IL9422790A patent/IL94227A/en not_active IP Right Cessation
- 1990-04-27 PL PL90284970A patent/PL166810B1/pl unknown
- 1990-04-27 ES ES90906939T patent/ES2055427T3/es not_active Expired - Lifetime
- 1990-04-27 KR KR1019910701462A patent/KR920701241A/ko not_active Ceased
- 1990-04-27 FI FI914995A patent/FI914995A7/fi unknown
- 1990-04-27 EP EP90906939A patent/EP0470136B1/en not_active Expired - Lifetime
- 1990-04-27 DD DD90340234A patent/DD296960A5/de not_active IP Right Cessation
- 1990-04-27 AT AT90906939T patent/ATE107660T1/de not_active IP Right Cessation
- 1990-04-27 WO PCT/EP1990/000647 patent/WO1990013561A1/en active IP Right Grant
- 1990-04-27 AU AU55472/90A patent/AU631641B2/en not_active Ceased
- 1990-04-27 PT PT93921A patent/PT93921B/pt not_active IP Right Cessation
- 1990-04-27 CN CN90103907A patent/CN1047340A/zh active Pending
- 1990-04-27 HU HU903342A patent/HUT58345A/hu unknown
- 1990-04-27 ZA ZA903228A patent/ZA903228B/xx unknown
- 1990-04-27 CA CA002056402A patent/CA2056402C/en not_active Expired - Fee Related
- 1990-04-27 RU SU905010237A patent/RU2074891C1/ru active
- 1990-04-27 RO RO148615A patent/RO112032B1/ro unknown
- 1990-04-27 NZ NZ233475A patent/NZ233475A/xx unknown
- 1990-04-27 MX MX2050390A patent/MX20503A/es unknown
- 1990-04-27 IE IE153890A patent/IE64351B1/en not_active IP Right Cessation
- 1990-04-27 DK DK90906939.5T patent/DK0470136T3/da active
- 1990-04-27 JP JP2506560A patent/JPH04506003A/ja active Pending
- 1990-04-29 EG EG24990A patent/EG19583A/xx active
- 1990-05-04 YU YU87090A patent/YU87090A/sh unknown
-
1991
- 1991-10-24 BG BG95362A patent/BG60916B1/bg unknown
- 1991-10-25 NO NO91914206A patent/NO914206L/no unknown
- 1991-11-25 IN IN873MA1991 patent/IN173230B/en unknown
-
1993
- 1993-04-02 HR HR930700A patent/HRP930700A2/hr not_active Application Discontinuation
- 1993-06-19 LV LVP-93-624A patent/LV10200B/xx unknown
- 1993-12-21 LT LTIP1645A patent/LT3827B/lt not_active IP Right Cessation
-
1994
- 1994-09-08 US US08/302,369 patent/US5468480A/en not_active Expired - Fee Related
-
1995
- 1995-06-30 HU HU95P/P00687P patent/HU211746A9/hu unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2055427T3 (es) | Agente terapeutico. | |
| ES2057124T3 (es) | Producto terapeutico para el tratamiento de estados peri- o post-menopausicos. | |
| ES2191034T3 (es) | Formulaciones de liberacion controlada para la liberacion de metoprolol durante 24 horas. | |
| ES2059446T3 (es) | Composicion de copolimero bloque hidrogenado especifico y procedimiento para su fabricacion. | |
| ES2036737T3 (es) | Procedimiento para la obtencion de mezclas farmaceuticas. | |
| ES2194935T3 (es) | Preparados estables de transglutaminasa y procedimiento para su preparacion. | |
| DE69427127D1 (de) | Substituierte tetra- und pentapeptid hemmstoffe der farnesyl protein transferase | |
| AR002754A1 (es) | Composición farmacéutica que comprende bacterias lactobacillus viables micro-encapsuladas, y uso de la composición para preparar de un medicamento | |
| NZ228130A (en) | Therapeutic composition comprising fenofibrate and a solid surfactant which has been co-micronised; preparatory process | |
| NO944997D0 (no) | Trombin-blodfraksjon for anvendelse ved en medisinsk fremgangsmåte | |
| AR005650A1 (es) | Metodo para inhibir el fotoenvejecimiento de la piel humana no danada por la radiacion uvb mediante inhibidores de la sintesis y/o actividad de mmp y lautilizacion de dichos inhibidores en la preparacion de medicamentos para prevenir dicho envejecimiento. | |
| ES2156840T1 (es) | Medicamento que contiene polisulfato de pentosano e implante para tratar la fibrosis. | |
| ATE29215T1 (de) | Diaethylpropionpraeparate mit verzoegerter wirkung. | |
| NZ235337A (en) | Pharmaceutical composition containing anticoagulant (e.g. warfarin) and a platelet inhibitory agent for treating/preventing myocardial infarction and stroke | |
| DK579088D0 (da) | Substituerede tetraliner, chromaner og beslaegtede forbindelser, farmaceutiske praeparater indeholdende disse og forbindelser til anvendelse som udgangsmateriale ved deres fremstilling | |
| MX9710252A (es) | Utilizacion de al menos un peptido en una composicion cosmetica o para la preparacion de un medicamento. | |
| BR9201253A (pt) | Composto,processo para a sua preparacao,agente diagnostico ou terapeutico e aplicacao do mencionado composto | |
| ES2063767T3 (es) | Esteres aromaticos policiclicos de antibioticos macrolidicos y lincosamidicos, su procedimiento de preparacion y composiciones farmaceuticas y cosmeticas que los contienen. | |
| HU9601684D0 (en) | Deuterised active agents in transdermal application | |
| MX9300558A (es) | Nueva sulfonilurea, procedimiento para su preparacion y formulado farmaceutico que la contiene. | |
| DK88087D0 (da) | Tricyklisk 5-(3-chlor-6-methyl-5,5-dioxo-6,11-dihydro-dibenzo-(c,f)-(1,2)-thiazepin-11-yl)-amino-pentansyrederivat, fremgangsmaade til fremstilling deraf og farmaceutiske midler indeholdende dem | |
| NO922136D0 (no) | Anvendelse av gibberelliner for behandling av prostatitisog psoriasis | |
| AU2135688A (en) | Pharmaceutical composition for preventing and treating bacterial or viral diseases | |
| CO4600680A1 (es) | Procedimientos para la prevencion de la degradacion de la proteina c | |
| AU3406089A (en) | Novel strobilurine derivatives, their preparation and their use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 470136 Country of ref document: ES |